Kiniksa Pharmaceuticals International, plc Annual Depreciation in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Depreciation history and growth rate from 2017 to 2023.
  • Kiniksa Pharmaceuticals International, plc Depreciation for the quarter ending September 30, 2024 was $87K, a 70.2% decline year-over-year.
  • Kiniksa Pharmaceuticals International, plc Depreciation for the twelve months ending September 30, 2024 was $596K, a 48.9% decline year-over-year.
  • Kiniksa Pharmaceuticals International, plc annual Depreciation for 2023 was $1.11M, a 5.94% decline from 2022.
  • Kiniksa Pharmaceuticals International, plc annual Depreciation for 2022 was $1.18M, a 19% decline from 2021.
  • Kiniksa Pharmaceuticals International, plc annual Depreciation for 2021 was $1.46M, a 39.5% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.11M -$70K -5.94% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $1.18M -$276K -19% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $1.46M -$950K -39.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $2.41M +$337K +16.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $2.07M +$1.78M +623% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $286K +$258K +921% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $28K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.